Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - general & plastic surgery - the encor ultra breast biopsy system is indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities. it is intended to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality. it is intended to provide breast tissue for histologic examination with partial removal of a palpable abnormality.

Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - general & plastic surgery - the encor breast biopsy system is indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities. it is intended to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality.

Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - general & plastic surgery - the encor enspire™ breast biopsy system is indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities.it is intended to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality and partial removal a palpable abnormality.

Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - general & plastic surgery - the gel mark ultra is intended to radiographically mark breast tissue during a percutaneous biopsy procedure.

Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - general & plastic surgery - the gel mark ultra biopsy markers (titanium) is indicated for use to radiographically mark breast tissue during a percutaneous breast biopsy procedure.

Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - obstetrics & gynaecology - the senomark ultracor mri is intended to radiographically and sonographically mark breast tissue prior to or during a breast biopsy procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

bard australia pty ltd - 16835 - biopsy kit, soft tissue - a collection of equipment (biopsy needles/probes and dedicated introducers, etc.) used to acquire breast tissue for diagnostic sampling.

Australia - English - Department of Health (Therapeutic Goods Administration)

bard australia pty ltd - 40808 - marker, lesion localization, implantable - a disposable applicator containing resorbable polylactic acid/polyglycolic acid (pla/pga) pellets with an embedded stainless steel radiopaque wireform, intended for long term radiographic marking of the biospy site. pellets are visible via ultrasound for approx. 6 weeks and resorbed in approx. 12 weeks. the pellets are deployed from the applicator through the biopsy device into the biopsy cavity. an implant used to radiographically mark breast tissue during a percutaneous breast biopsy procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

bard australia pty ltd - 40808 - marker, lesion localization, implantable - a disposable applicator containing resorbable polylactic acid/polyglycolic acid (pla/pga) pellets with an embedded titanium radiopaque wireform, intended for long term radiographic marking of the biospy site. pellets are visible via ultrasound for approx. 6 weeks and resorbed in approx. 12 weeks. the pellets are deployed from the applicator through the biopsy device into the biopsy cavity. an implant used to radiographically mark breast tissue during a percutaneous breast biopsy procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

bard australia pty ltd - 40808 - marker, lesion localization, implantable - a disposable applicator containing 3 resorbable polyglycolic acid (pga) pads, the centre pad containing a stainless steel wireform. a polyethylene glycol (peg) push pad is present at the end. the wireform is intended for long term radiographic marking of the biopsy site. the pads are visible via ultrasound for approx. 3 weeks and resorbed in approx. 12 weeks. the applicator provides access to the biopsy site and is used to deploy the pads into the biopsy cavity. an implant used to radiographically and sonographically mark breast tissue during a percutaneous breast biopsy procedure.